WASHINGTON, D.C. – U.S. Senators Susan Collins (R-ME), Debbie Stabenow (D-MI), Edward J. Markey (D-MA), and Shelley Moore Capito (R-WV) today announced that the Centers for Medicare & Medicaid Services has proposed covering new care planning sessions under Medicare for Alzheimer’s patients and their families to provide an early assessment of the disease and possible treatment options.
This proposal would effectively implement the Health Outcomes, Planning and Education (HOPE) for Alzheimer’s Act, which requires Medicare to pay for a care planning session. The HOPE Act is coauthored by Senators Collins, Stabenow, Capito, and Markey and cosponsored by 54 other Senators.
"By allowing Medicare beneficiaries to receive a care planning session, this proposed rule would provide essential support for newly-diagnosed individuals and their families who are facing Alzheimer’s,” said Senator Collins. “I am pleased that CMS has recognized the importance of this benefit, which was one of the provisions in our HOPE for Alzheimer’s Act. As the Co-Chair of the Senate Alzheimer’s Task Force, I will continue to work to ensure that Alzheimer’s patients and their caregivers have the support they need.”
“This announcement is hugely important to those living with Alzheimer's disease and the loved ones who help care for them every day,” said Senator Stabenow. “Our HOPE for Alzheimer’s Act called for care planning sessions for Alzheimer’s patients and their families and I’m pleased that CMS is now proposing to cover these vital services under Medicare. While there's more work to be done in the fight against Alzheimer’s disease, this is a strong sign that additional support and services are on the way.”
The HOPE for Alzheimer’s Act creates a new care-management planning session for newly diagnosed Alzheimer's patients under Medicare. This new benefit would encourage doctors to give a clear diagnosis to patients with Alzheimer’s disease, including information about treatment options and what medical and community services are available.